SIRT1 and Alzheimer disease: Along the same lines, resveratrol reduced the activity of β-secretase (BACE1), essential for the production of Aβ amyloid species, through the activation of SIRT1 in rodent models of AD (Table 1) [125, 126], confirming its ability to reduce the amyloidogenic pathway.